Clinical Trial Update: The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating L-carnitine and biotin as adjunctive therapies in children with moderate persistent asthma; the study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Asthma

Drugs mentioned

• BIotiN (biotin)
• L-carnitine (L-carnitine)

Snippet

Sponsor: Tanta University | Conditions: Moderate Persistent Asthma | Phase 3 | Status: UNKNOWN